Other recent publications have also implicated a role for Grem1 in regulating epithelial-mesenchymal transition24 and lineage plasticity through direct activation of the fibroblast growth factor receptor 125 in pancreatic cancer and prostate cancer, respectively. This evidence concerns the gene GREM1 and Familial prostate cancer.